Cargando…
Trichostatin A promotes GLI1 degradation and P21 expression in multiple myeloma cells
BACKGROUND: Histone deacetylase inhibitors are promising drugs for the future application in cancer therapy. Trichostatin A (TSA), a histone deacetylase inhibitor, exhibits effective antitumor effects in various cancers. However, the effects and underlying mechanisms of TSA on multiple myeloma (MM)...
Autores principales: | Geng, Yan, Liu, Jing, Xie, Ying, Jiang, Hongmei, Zuo, Kai, Li, Tao, Liu, Zhiqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6118243/ https://www.ncbi.nlm.nih.gov/pubmed/30214285 http://dx.doi.org/10.2147/CMAR.S167330 |
Ejemplares similares
-
Alu-dependent RNA editing of GLI1 promotes malignant regeneration in multiple myeloma
por: Lazzari, Elisa, et al.
Publicado: (2017) -
Anti-Proliferative Activity of HPOB against Multiple Myeloma Cells via p21 Transcriptional Activation
por: Liu, Linlin, et al.
Publicado: (2018) -
Trichostatin A Promotes the Generation and Suppressive Functions of Regulatory T Cells
por: Doñas, Cristian, et al.
Publicado: (2013) -
Deacetylation induced nuclear condensation of HP1γ promotes multiple myeloma drug resistance
por: Li, Xin, et al.
Publicado: (2023) -
Hypoxia-induced CREB cooperates MMSET to modify chromatin and promote DKK1 expression in multiple myeloma
por: Xu, Yinyin, et al.
Publicado: (2021)